An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma

BACKGROUND: For pancreatic ductal adenocarcinoma (PDAC) patients, chemotherapy failure is the major reason for postoperative recurrence and poor outcomes. Establishment of novel biomarkers and models for predicting chemotherapeutic efficacy may provide survival benefits by tailoring treatments. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Zengyu, Li, Kexian, Lou, Jianyao, Wu, Yulian, Peng, Chenghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119901/
https://www.ncbi.nlm.nih.gov/pubmed/33996821
http://dx.doi.org/10.3389/fcell.2021.665161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119901/
https://www.ncbi.nlm.nih.gov/pubmed/33996821
http://dx.doi.org/10.3389/fcell.2021.665161

Ejemplares similares